These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18646497)

  • 1. Natamycin treatment of experimental Candida albicans induced keratomycosis in rabbits.
    Saleem M; Rahman A; Afza N
    West Indian Med J; 2007 Dec; 56(6):526-9. PubMed ID: 18646497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natamycin (pimaricin) in the treatment of experimental keratomycosis].
    Behrens-Baumann W; Klinge B
    Fortschr Ophthalmol; 1990; 87(3):237-40. PubMed ID: 2376371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.
    Gyanfosu L; Koffuor GA; Kyei S; Ababio-Danso B; Peprah-Donkor K; Nyansah WB; Asare F
    Int Ophthalmol; 2018 Oct; 38(5):2089-2100. PubMed ID: 28900810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
    Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clotrimazole and bifonazole in the topical treatment of Candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Uter W
    Mycoses; 1990; 33(11-12):567-73. PubMed ID: 2103595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally administered antifungal therapy for experimental keratomycosis.
    O'Day DM
    Trans Am Ophthalmol Soc; 1990; 88():685-725. PubMed ID: 2095036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits.
    Pleyer U; Legmann A; Mondino BJ; Lee DA
    Am J Ophthalmol; 1992 Mar; 113(3):303-8. PubMed ID: 1543224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
    Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
    Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.
    Hassan HA; Geniady MM; Abdelwahab SF; Abd-Elghany MI; Sarhan HA; Abdelghany AA; Kamel MS; Rodriguez AE; Alio JL
    Ophthalmic Res; 2018; 60(2):69-79. PubMed ID: 29969774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact lens-induced infection--a new model of Candida albicans keratitis.
    O'Day DM; Head WS; Robinson RD; Yang R; Shetlar D; Wang MX
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1607-11. PubMed ID: 10359345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Antifungal Soaked Silicone Hydrogel Contact Lenses on Candida albicans in an Agar Eye Model.
    Phan CM; Bajgrowicz M; McCanna DJ; Subbaraman LN; Jones L
    Eye Contact Lens; 2016 Sep; 42(5):313-7. PubMed ID: 26595214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic lamellar keratectomy in the management of experimental keratomycosis.
    Tseng SH; Tang KY; Chao SC; Hsu MM
    J Formos Med Assoc; 1994 Apr; 93(4):300-6. PubMed ID: 7914771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
    Habib FS; Fouad EA; Abdel-Rhaman MS; Fathalla D
    Acta Ophthalmol; 2010 Dec; 88(8):901-4. PubMed ID: 19681761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of extracellular phospholipase B of Candida albicans as a virulent factor in experimental keratomycosis.
    Ma L; Xie L; Dong X; Shi W
    Curr Eye Res; 2009 Sep; 34(9):761-8. PubMed ID: 19839869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans should be considered when managing keratitis in Atopic keratoconjunctivitis.
    Nivenius E; Montan P
    Acta Ophthalmol; 2015 Sep; 93(6):579-80. PubMed ID: 25923050
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
    Mahdy RA; Nada WM; Wageh MM
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):281-5. PubMed ID: 20565316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
    Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006).
    Ledbetter EC; Patten VH; Scarlett JM; Vermeylen FM
    J Am Vet Med Assoc; 2007 Oct; 231(7):1086-91. PubMed ID: 17916036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.